移植后的恶性瘤;一个基本概念
Zahid Nabi1, Tabeer Zahid2, Rayyan Nabi3
1Nephrology Department KRL Hospital Islamabad, Pakistan.
Journal of Ayub Medical College, Abbottabad : JAMC
|February 26, 2024
概括
接受移植的人面临着由于免疫抑制剂和病毒因素而增加的癌症风险. 早期检测和多学科护理对于治疗移植后恶性瘤和改善患者的治疗结果至关重要.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 在瘤学瘤学.
- 移植免疫学 移植免疫学
背景情况:
- 移植为慢性病提供了更好的结果,但也伴随着风险.
- 移植后恶性瘤是死亡的一个重要原因,与免疫抑制剂和病毒感染有关.
- 特定的癌症,如卡波西肉瘤,淋巴瘤和非黑色素瘤皮肤癌更为普遍.
研究的目的:
- 突出移植患者恶性瘤的风险增加和预后较差.
- 强调导致移植后癌症的机制,包括药物效应和病毒性瘤发生.
- 倡导在移植管理中进行综合癌症风险评估和查.
主要方法:
- 对移植后恶性瘤现有文献的综述.
- 风险因素的分析,包括免疫抑制药物和病毒影响.
- 讨论移植受体的诊断和管理策略.
主要成果:
- 免疫抑制通过直接药物效应,病毒控制受损和免疫监测减少,增加癌症风险.
- 捐赠者传播的癌症是一种可能性,可以通过两年的时间框架来区分.
- 移植患者的恶性瘤往往有较差的预后与非移植个体相比.
结论:
- 量化癌症风险和实施查是移植护理的重要组成部分.
- 涉及早期检测和及时治疗的多学科方法对于改善结果至关重要.
- 移植中心必须优先管理患者癌症负担的增加.
相关概念视频
Bone Marrow Sampling and Transplants
330
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
330
Tissue Transplantation
366
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
366
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K


